Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Document › Details

Uniqure N.V.. (8/8/18). "Press Release: Uniqure Announces Second Quarter 2018 Financial Results and Highlights Company Progress". Lexington, MA & Amsterdam.

Organisation Organisation Uniqure N.V. (Nasdaq: QURE)
  Group Uniqure (Group)
Products Product AMT-061 (hemophilia B gene therapy, Uniqure)
  Product 2 AMT-130 (Uniqure)
Persons Person Kapusta, Matthew (Uniqure 201612– CEO before interim CEO before CFO before AngioDynamics + Smith & Nephew Orthopaedics)
  Person 2 Gut, Robert (Uniqure 201808– CMO before Versartis Inc + Novo Nordisk Inc)
     


   
Record changed: 2018-08-11

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Uniqure (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top